S&P; BSE PHARMA index has continually underperformed SENSEX in the last 1/3/6/12-months as the sector continues to face headwinds due to 1) fierce competition, 2) shorter time-to-market, 3) expiring patents, 4) slowing sales growth, 5) declining profitability in developed markets. Thus they need to find solutions to beat these challenges. Additional woes adding on the domestic front are the...